Endocrine oncology

Preliminary Report Examining Efficacy and Safety of Radiofrequency Ablation for the Treatment of Skin-Involving Recurrent Thyroid Cancer

ThyroidPublished Retrospective case series

Authors' conclusion

RFA might serve as a promising approach for managing skin-involving recurrent thyroid cancer, with no major complications reported in this preliminary study. Recurrent tumors involving the epidermis/dermis may pose a higher risk of skin burns than tumors involving the hypodermis.

Study context

Population
Patients with skin-involving recurrent thyroid cancer treated with ultrasound (US)-guided radiofrequency ablation (RFA), May 2008–March 2023; mean age 67.9 ± 14.4 years; 31 females; 50 tumors50 tumors
Participants
43 patients
Exposure
Epidermis/dermis vs Hypodermis
  • Hypodermisn = 31reference
Outcome
Technique efficacy (absence of detectable vasculature and volume reduction)
Follow-up
1 year
Methodological details88 RFA sessions (mean, 1.8; range: 1-6)
  • 88 RFA sessions (mean, 1.8; range: 1-6)

Main finding

As reported in the abstract

Technique efficacy, all tumors (36/50)

72%

CI: 59.6–84.4%

Observational data: associations, not effects.

Further findings

Subgroup: technique efficacy, epidermis/dermis vs hypodermis · no statistical difference

P = 0.085

Subgroup: clinical success rate · no statistical difference

P = 0.265

Subgroup: complete disappearance rate · no statistical difference

P = 0.541

Mean

OutcomeEpidermis/dermisHypodermisP value
Subgroup: mean VRRNo statistical difference65.5%84.6%P = 0.141

Clinical success, complete disappearance and volume reduction ratio (VRR), all tumors · last follow-up (median [IQR]: 2.7 [1.1-4.5] years)

Clinical success rate (44/50)
86%
Complete disappearance rate (27/50)
54%
Mean VRR
77.3% ± 44.2%

Safety

OutcomeEpidermis/dermisHypodermis
Skin burns per treatment session4.9% (CI 0–11.3%)0 events
  • Skin burns per treatment session: 2/41 epidermis/dermis procedures

Life-threatening or major complications

Patients with life-threatening or major complications
0

Original publication

Preliminary Report Examining Efficacy and Safety of Radiofrequency Ablation for the Treatment of Skin-Involving Recurrent Thyroid Cancer. Thyroid. Published 17 December 2024. doi:10.1089/thy.2024.0339

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.